Brain Tumor

23-NEU-4189360-hydrogen-sulfide-650×450

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

Cleveland Clinic researchers pursue answers on basic science and clinical fronts

SpineBoard-CQD-Hero-650×450
June 23, 2023/Cancer

How and Why a Dedicated Spine Tumor Board Can Enhance Care of Complex Patients

Insights from 15 years of experience of Cleveland Clinic’s spine tumor board

23-NEU-3909258-CQD-Hero-650×450-NEW

Mitochondria Transfer From Healthy Astrocytes Fuels Glioblastoma Tumorigenicity

Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets

MRI of a patient with brain metastases
April 25, 2023/Cancer

Management of Lung Cancer Brain Metastases: An Update

We now have an expanded toolbox to extend survival and lessen treatment toxicity

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-3282448_brain-tumor_650x450
January 24, 2023/Cancer

Study Explores Optimal Dosage of Novel Combination Therapy for Recurrent Glioblastoma

Focused ultrasound is paired with ALA to utilize sonodynamic therapy to target cancer cells

22-NEU-3409069-CQD-Hero-650×450
December 20, 2022/Cancer

Survival Is Associated With Subsets of T Cells in Recurrent Glioblastoma Treated With SL-701

Can T-cell immunophenotyping help inform treatment decisions?

22-NEU-3367462-T-cells-650×450
December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

22-NEU-2826664-CQD-Hero-650×450 (1)
October 12, 2022/Brain Tumor

Trigeminal Schwannoma: Two Surgical Options for Two Distinct Cases

Insights into the choice between craniotomy and endoscopic endonasal approaches

22-NEU-3204009-CQD-Hero-650×450
October 11, 2022/Brain Tumor

Does Extended Use of Prophylactic Antibiotics Improve Nasal Healing After Endoscopic Transsphenoidal Surgery?

Randomized controlled trial finds no quality-of-life benefit after standard pituitary tumor surgery

22-NEU-3216908-CQD-Hero2-650×450
October 6, 2022/Cancer

Belzutifan for VHL-Associated CNS Hemangioblastoma: Here’s What Early Radiologic Response Looks Like

First reported imaging findings show swift reductions in perilesional edema, tumor size

BackPage 1 of 2Next
Advertisement
Ad